SCHEMBL3140974

SCHEMBL3140974

[O-][Cl+3]([O-])([O-])OS(c1ccccc1)(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.42
PTGS2 P35354 2/20 0.38
PTGS1 P23219 1/20 0.38
KMT2A Q03164 3/20 0.36
FFAR1 O14842 2/20 0.36
FFAR4 Q5NUL3 1/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35
TSHR P16473 2/20 0.35
ALOX15 P16050 1/20 0.35
RECQL P46063 1/20 0.35
MEN1 O00255 1/20 0.35
HSD11B1 P28845 1/20 0.35
NFE2L2 Q16236 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3139597 1.00 PKM (0.42) PKMPTGS2PTGS1KMT2AFFAR1
SCHEMBL108184 0.89 HTR6 (0.36) PKMPTGS2KMT2AALDH1A1TSHR
SCHEMBL3136673 0.80 TDP1 (0.43) PTGS2PTGS1KMT2AALDH1A1TSHR
SCHEMBL3132383 0.80 TDP1 (0.43) PTGS2PTGS1KMT2AALDH1A1TSHR
SCHEMBL3135940 0.80 HTT (0.42) KMT2AFFAR1ALDH1A1TSHRMEN1
SCHEMBL3134808 0.80 HTT (0.42) KMT2AFFAR1ALDH1A1TSHRMEN1
SCHEMBL3126953 0.80 ESR1 (0.39) PTGS2PTGS1KMT2AMEN1
SCHEMBL3139994 0.79 ALDH1A1 (0.45) KMT2AALDH1A1TSHRMEN1HSD11B1
SCHEMBL3132410 0.79 ALDH1A1 (0.45) KMT2AALDH1A1TSHRMEN1HSD11B1
SCHEMBL3144342 0.77 CA4 (0.46) PKMALDH1A1HSD11B1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642368-B2 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-01-05 US disclosed
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2007-04-12 US disclosed
EP-1676835-A1 PROCESS FOR PRODUCING TRIARYLSULFONIUM SALT Wako Pure Chemical Industries, Ltd. (JP) 2006-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid ARSA, HAO2, HAO1 PKM 3805/4885PTGS2 1519/4885PTGS1 561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.